Post My Press Release

Free Press Release Distribution

Category: General (Page 1 of 9387)

Microbiome Therapeutics Market – Latest Trends and Future Growth Study by 2026

Global Microbiome Therapeutics Market: Overview

The global microbiome therapeutics market is anticipated to rise progressively owing to the growing need for precise, reliable, and fast treatment for diseases like phenylketonuria, hepatic encephalopathy, C. difficile infection (CDI), and multidrug resistant urinary tract infection. Orphan drug approvals and advance therapy designation for microbiome therapeutics is expected to fasten the launch of developmental drugs in the microbiome therapeutics market. There is huge potential for growth of this market, as more than 120 candidates drug are in pipeline in different stages of development that will benefit the microbiome therapeutics market.

Read Report Overview:

The global microbiome therapeutics market could be classified on the basis of indication and region. Based on indication, the market is further divided into type 2 diabetes, clostridium difficile infection (CDI), obesity, and primary hyperoxyurea. During the forecast period, C. difficile infection segment is projected to lead the market. Moreover, increasing number of product approval for CDI is expected to increase the number of share held by this segment.

The report offered here gives a phenomenal explanation of how some factors could serve to up the demand in the global microbiome therapeutics market. It also provides useful information about the market segmentation, competitive landscape, and other aspects of the global wireless fetal monitoring systems market.

Global Microbiome Therapeutics Market: Trends and Opportunities

The results derived from the human microbiome project and other similar studies done on human bacterial symbioses have drawn large attention from applied biomedical research organizations. The human microbiome has led to the identification of 600 microbial reference genome, 60 Mn genes, and sequencing of 700 metagenomes. While MetaHIT catalogue comprises of 3.3 Mn essential human microbiome genes in nearly every set of genes for human gut microbiome. With improved microbiome sequencing capabilities, the global microbiome therapeutics market is expected to flourish during the forecast years. Therefore, this may lead to more research in microbiome sequencing and may discover further diversity of microbiome that will help in finding new and better microbiome therapeutics. Moreover, increasing collaboration between pharmaceuticals companies for developing new drugs may help in generating better drugs that will act as growth aggregator for this market.

Global Microbiome Therapeutics Market: Regional Analysis

North America is envisaged to lead the global microbiome therapeutics market while accounting for a sizable share in the next few years. Development of new therapeutics and rising healthcare expenditure could augur well for the North America microbiome therapeutics market. In addition to that presence of key players in the region has contributed in maintain the dominance in the market.

Request Brochure of the Report:

Europe is also expected to grow considerably in coming years and can hold substantial amount of market share in the global microbiome therapeutics market. However, Asia pacific is expected to grow significantly due to high number of biological research activities in national institutes, increasing economic stability, and rising awareness among physicians concerning new therapeutics in the region.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Asherson’s Syndrome Diagnostic and Treatment Market to be at Forefront by 2026

Asherson’s syndrome is rare autoimmune disorder. It is also known catastrophic antiphospholipid syndrome. An autoimmune disorder causes antibodies to attack normal cells of the body by mistake. In Asherson’s syndrome patients, abnormal antiphospholipid antibodies attack proteins and fats in the blood, specifically phospholipids.

Read Report Overview:

Signs and symptoms of Asherson’s syndrome incude deep vein thrombosis (DVT), pulmonary embolism (PE), complications in pregnancy, and ischemic stroke. Headaches or migraines, livedo reticularis, seizures and dementia are less common signs and symptoms. In very rare case, patients may develop memory problems, hearing loss, progressive breathlessness, depression, or psychosis. Symptoms generally appear between the ages of 20 and 50 years.

Increase in the prevalence of Asherson’s syndrome worldwide is anticipated to boost the Asherson’s syndrome diagnostic and treatment market during the forecast period. Lifestyle changes are also fueling the market. Rise in government prioritization of drugs for rare disorders is also likely to boost the Asherson’s syndrome diagnostic and treatment market in the near future. However, lack of knowledge about Asherson’s syndrome is a major restrain of the market. Dearth of health care experts in Latin America and Middle East & Africa also limit the growth of the Asherson’s syndrome diagnostic and treatment market in the regions. Nevertheless, increasing government funding for diagnosis procedures is likely to offer attractive opportunities for the Asherson’s syndrome diagnostic and treatment market.

DownloadBrochureCopy of this Report:  

The global Asherson’s syndrome diagnostic and treatment market can be segmented based on treatment, diagnostic test, end-user, and region. In terms of treatment, the market can be classified into anticoagulant, corticosteroids, steroids, immunoglobulins, and plasmapheresis. Heparin is an anticoagulant drug used for the treatment of Asherson’s syndrome. The main goal of Asherson’s syndrome treatment is to thin the blood in order to reduce the chances of clotting. In pregnancy, doctors do not recommend Warfarin as it can cause birth defects. Intravenous immunoglobulin infusions and corticosteroids, such as prednisone, may be prescribed if the patient does not respond to aspirin, heparin, or both.

In terms of end-user, the global Asherson’s syndrome diagnostic and treatment market can be categorized into hospitals and others. The hospitals segment held a prominent share of the market in 2017.

View TOC with Figures and Tables:

In terms of region, the global Asherson’s syndrome diagnostic and treatment market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for a significant share of the global market in 2017, followed by Europe and Asia Pacific. The U.S. held a major share of the market in North America in terms of revenue. The Asherson’s syndrome diagnostic and treatment market in Asia Pacific is growing rapidly due to an increase in the number of patients suffering from the disorder in the region. Asia Pacific is projected to be a highly attractive region of the Asherson’s syndrome and treatment market in the near future. This is due to the presence of emerging economies such as India and China in the region. Moreover, factors such as better health care infrastructure, economic growth, rise in the number of insurance payers, expanding and developing private health care sector, and increase in awareness among people regarding Asherson’s syndrome diagnostic and treatment are expected to propel the market in the region in the next few years. The Asherson’s syndrome diagnostic and treatment market in Latin America and Middle East & Africa is projected to expand at a moderate growth rate from 2018 to 2026.

Key players operating in the global Asherson’s syndrome diagnostic and treatment market include Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Shenzhen Techdow Pharmaceutical Co., Ltd, Baxter, B. Braun Melsungen AG, Fresenius Kabi USA, Mylan N.V., and Novartis AG.

Surgical Lamps Market Analysis, Trends, Opportunity, Market Size and Segment Forecasts 2018 -2026

Global Surgical Lamps Market: Overview

Surgical lamps is medical devices used as an integral part during surgeries and invasive medical procedures. Surgical lamps creates illumination that helps in visualization of low contrast objects and small cavities. Surgical lamps are widely used by surgeons in dental surgery, optical surgery, neurosurgery, and endoscopic surgery. Moreover, these devices provide optimally shadow-free and bright high-intensity light that helps in seamless visualization of low-contrast and small objects within the body cavity during surgeries. Surgical lamps are widely used in ambulatory surgery centers and operating rooms in hospitals.

Report Overview @

The global surgical lamps market could be categorized on the basis of technology, types of light, product type, and geography. Based on the product type, the global surgical lamps market may include laser light lamps, dental light lamps, ceiling mount surgical lamps, and surgical headlight lamps. Compact fluorescent lamps (CFLs) surgical light lamp, light emitting diode (LED) surgical light lamps, and halogen surgical light lamps on which technology used in surgical lamps is divided. Of these, LEDs surgical lamps are projected to lead technology type segment in this market during the forecast period.

The report makes a strong effort to analyze various aspects and factors responsible for the growth of the market. It is considered as one of the finest elaborations on how the global market for surgical lamps will shape in the coming years.

Request Brochure @

Global Surgical Lamps Market: Trends and Opportunities

Technological advancements have renovated surgical lamps and have grown more opportunities for the global surgical lamps the surgical lamps plays an essential role during surgeries their demand have grown substantially in the health care sector in past few years and is projected to grow significantly in the coming years. Moreover, rising demand for specification in surgical lamps such as color rendering Index (CRI), brightness, homogeneity, shadow dilution, correlated color temperature (CCT), and many others have widened the scope of the market and for manufacturers as well. Moreover, increasing efforts in research and development and for developing advanced surgical tools used during surgeries and growing government initiatives to implement energy efficient surgical lamps in the healthcare sector are expected to benefit the surgical lamps market in coming years.

Global Surgical Lamps Market: Geographical Analysis

North America is expected to lead the global surgical lamps market during the forecast period from 2018 to 2026. The major reason for the dominance of this region is because of increasing number of surgeries in the United States. In terms of revenue, North America is projected to cross millions by the end of forecast period in 2026. In addition, Europe is considered as a lucrative market for the growth of surgical lamps due to favorable government initiatives existing in the region. Besides Europe, Asia Pacific is projected to expand the production of cost-effective yet advanced surgical lamps.

Request for TOC @

Global Surgical Lamps Market: Companies Mentioned

Globally, the surgical lamps market comprises of leading companies such as Integra LifeSciences Corporation, Steris Corporation, Welch Allyn, DRE INC., Skytron, A-dec, Inc., and Stryker Corporation. All of these companies are studied distinctively in the report focusing on their market share and recent developments. Opportunities for the manufacturers producing surgical lamps are also increasing with the growing need for surgical lamps. Growing demand for cost effective surgical lamps with specifications are also projected to benefit the manufacturers in coming years.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453



Sulfur Hexafluoride Market is expected to reach US$ 340.75 Mn by 2026

In terms of value, the global sulfur hexafluoride market is projected to expand at a CAGR of 6.3% from 2018 to 2026, according to a new research report titled ‘Sulfur hexafluoride Market – Global Industry Analysis, Value, Share, Growth, Trends, and Forecast, 2018–2026’ published by Transparency Market Research (TMR) .In terms of value, the global sulfur hexafluoride market is expected to reach US$ 340.75 Mn by 2026. The market is driven by the increase in electricity consumption across the globe. The sulfur hexafluoride market in Asia Pacific is estimated to expand at a CAGR of 6.4% during the forecast period owing to rising need for power utilities due to the increase in demand for homes and infrastructure development led by rapid increase in population in countries such as China and India. Based on grade, the technical grade segment accounted for a major share of the global sulfur hexafluoride market in 2017 and this trend is anticipated to continue during the forecast period.

Rising Electricity Consumption across Globe to Boost Market

Based on application, the electrical transmission and distribution segment accounted for major share of the sulfur hexafluoride market, in terms of value and volume, in 2017. This can be ascribed to the wide range of applications of sulfur hexafluoride in electrical transmission and distribution devices such as circuit breakers and gas insulated switch gears. Sulfur hexafluoride has no substitutes in high voltage and medium voltage circuit breakers and gas insulated switch gears due to its high dielectric strength. Rise in electricity consumption due to growing demand from residential, commercial, and industrial sectors and increase in development activities across the globe is projected to drive the global sulfur hexafluoride market.

Sulfur hexafluoride gas is utilized in leak detection applications and as a gaseous dielectric for circuit breakers, transformers, and condensers, as it possess superior performance properties such as excellent dielectric strength and thermal stability. The electricity requirement is fulfilled and transmitted through several distribution devices. Rise in installation of high voltage switchgear due to rapid industrialization is expected to boost the demand for sulfur hexafluoride during the estimated period.

Request A Sample –

Rise in Concerns Regarding Global Warming to Restrain Market

Sulfur hexafluoride is a key greenhouse gas with greenhouse potential (GWP) of 23500 for 100 years. Several tons of sulfur hexafluoride are released into the open atmosphere due to negligence during handling in various industries. The gas is included in the 1997 Kyoto Protocol and regulations have been implemented to regulate its emissions in the international policy. Rise in environmental concerns and regulations to control greenhouse effects are anticipated to hinder the global sulfur hexafluoride market during the forecast period.

Sulfur Hexafluoride Re-use Programs Offers Key Opportunities

Sulfur hexafluoride is essential in electrical transmission and distribution applications due to its unique properties such as non-toxicity, chemical inertness, high thermal stability, and non-flammability. However, its high GWP increases environmental concerns about global warming. Hence, reclaiming of sulfur hexafluoride gas from electrical installations is necessary and beneficial due to economic and ecological reasons. Development of sulfur hexafluoride re-use service includes reclaiming of used sulfur hexafluoride gas and analytical services for used sulfur hexafluoride, packaging, and transport of used sulfur hexafluoride can create lucrative opportunities for sulfur hexafluoride manufacturers.

In Terms of Volume and Value, Asia Pacific Accounts for Major Share of Global Market

Asia Pacific was the major region of the global sulfur hexafluoride market. In terms of volume and value, the region accounted for more than 40% share of the market in 2017. Initiatives by governments of developing economies such as India for affordable housing and infrastructure development are expected to drive metal manufacturing and construction industries in these countries in the near future. This factor is anticipated to boost the sulfur hexafluoride market during the forecast period.

China is a major country for the sulfur hexafluoride market. Key players operate in the market in the country along with several local and unorganized manufacturers. Based on demand, China constitutes a prominent share of the sulfur hexafluoride market in Asia Pacific due to rapid urbanization leading to the rise in need for power utilities in the country and established semiconductor manufacturing industry.

Request For Broucher@

Global Sulfur Hexafluoride Market is Fragmented   

The report comprises profiles of major companies operating in the global sulfur hexafluoride market. Global sulfur hexafluoride market is fragmented with the presence of global and local players. Key players include operating in the global market include Solvay, AGC Chemicals, Kanto Denka Kogyo Co., Ltd., SHOWA DENKO K.K., The Linde Group, Air Products and Chemicals, Inc., Air Liquide, Axcel Gases, Fujian Shaowu Yongfei Chemical Co., Ltd, Concorde Specialty Gasesc, Shandong Ruihua Fluoride Industry Co. Ltd, and Wuxi Tianzhi Chemical Technology Co., Ltd.  Market players have been profiled in terms of attributes such as company overview, financial overview, business strategies, and recent developments. The report also comprises a comparison matrix between the top players operating in the global sulfur hexafluoride market and analysis of their key strengths for 2017.

Drug and Gene Delivery Systems Market to be Worth US$ 917 Bn by 2025

The global market for drug and gene delivery systems features a largely consolidated vendor landscape with only a handful companies accounting for a dominant share in the overall market, observes Transparency Market Research in a recent report. So as to gain a larger hold on the market, companies are putting more emphasis on offering advanced products, ploughing more resources into R&D activities, and seeking new ways of expanding their product portfolios. Thus instances of strategic collaborations and partnerships in the drug and gene deliver market have increased significantly in the past few years.

Obtain Report Details @

The strategic collaboration between Panacea Pharmaceuticals and 3M Drug Delivery System in 2017 for the development of a new cancer vaccine is a good instance of this prevailing trend in the market. Some of the leading companies in the market are Boston Scientific Corporation, Epeius Biotechnologies Corporation, Human Stem Cells Institute, Boston Scientific Corporation, Baxter International, Inc., and AstraZeneca plc.

According to the report, the global drug and gene delivery market, which valued at US$510 bn in 2016, will expand at a promising CAGR of over 6% over the period between 2017 and 2025.

Request for Sample Copy of Report @

North America and Europe to Remain Most Lucrative Regional Markets

Of the key drugs delivery systems associated with the drug and gene delivery systems market examined in the report, the segment of targeted drug delivery is expected to account for the dominant share in the overall market over the report’s forecast period; in terms of gene delivery systems, the segment of viral gene delivery system is likely to hold sway over the forecast period. Geographically, the markets in North America and Europe are expected to exhibit the most promising growth prospects over the report’s forecast period, thanks to the presence of some of the leading companies undertaking research in the field of drug and delivery in the regions.

Increased Funds Ploughed Into R&D Activities to Drive Market

One of the key factors expected to work in favor of the global drug and gene delivery systems market is the steady rise in R&D activities in the area as companies in the healthcare sector increasingly understand the need for more effective drug and gene delivery mechanisms for the treatment of the mounting cases of a variety of chronic diseases. According to JAMA oncology, nearly 17.5 million cancer cases were diagnosed across the globe and around 8.8 million deaths were caused by the disease in 2015. With focus on the effective treatment of the condition increasingly rising from governments as well as pharmacy companies, the market for drug and gene delivery systems is likely to benefit from the scenario.

Request Report Brochure @

The market is also driven by the rising numbers of new, advanced technologies making inroads in the field of drug and gene delivery and the rising application area of low dose targeted drug delivery. The increased demand for home health care and self-administering devices is also likely to work well in favor of the global drug and gene delivery systems market in the next few years. However, the market’s growth prospects could be hampered to a certain degree owing to the high cost of these treatment methods and several drug recalls to have hit companies in the past few years.

Building Automation System Market Key Players Outlook, Latest Trends and Forecast up to

The global building automation and control system market has observed a significant growth in recent years. The rise in the demand for energy-efficient systems and solutions, significant technological advancements of internet of things technology in building automation systems and solutions as well as increase in the construction activities in technologically advanced nations are the key factors which are propelling the growth of the said market.

 The electronic security and safety segment is expected to dominate the building automation system market during the forecast period. The capability of these electronic security and safety systems to monitor the activities, control access to buildings and thus protecting the staff, information as well as assests is the key factor which is propelling the growth of building automation market.

Request for Sample Report –

Asia-Pacific region is expected to grow at the highest rate during the forecast market. The major factors propelling the growth of the market in the region is the growing demand for safe and sustainable construction, rise in the disposable income of people and favourable government initiatives pertaining to smart cities. China, Japan and India are major countries which accounted for a majority share in the Asia-Pacific building automation system market.

This research report on global building automation system market provides in-depth analysis of the global building automation system market based on offering, application and major geographies for the period from 2016 to 2021. The report highlights the major market drivers pushing the growth and challenges faced by market participants. The research report provides market size and forecast for building automation system market. The report also analyses the competitive landscape and the major player and their market share in 2016. The competitive landscape section of the report also captures and highlights the recent development in the market.

The report also profiles the major companies active in this field, including Siemens AG, Johnson Controls International PLC, Schneider Electric SE, United Technologies Corp., Honeywell International Inc., Robert Bosch GmbH, Legrand SA, ABB Ltd., Lutron Electronics Co. Inc., Hubbell Inc.

Key questions this research would answer:
• Is the building automation system market growing? How long will it continue to grow and at what rate?
• What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
• What are the regional revenue and forecast breakdowns? What are the regional hotspots for growth in the building automation system market?

Request for Customization –

The global building automation system market is segmented on the basis of offering, application and geography:

Global Building Automation System Market by Offering
• Electronic Security & Safety
• Lighting Systems
• Energy Management Systems
• Others

Global Building Automation System Market by Application
• Residential
• Commercial
• Industrial

Global Building Automation System Market by Region
• North America
• Europe
• Asia-Pacific
• RoW

Global Building Automation System Market Competitive Landscape
• Major Players and their Market Share Analysis
• New product launches
• Mergers and acquisitions
• Collaborations, partnerships, agreements and joint ventures

For Additional Insights Click to Access Complete Report –

About GMI Research

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth. 

Media Contact

Company Name: GMI RESEARCH
Contact Person: Media Relations
Email: Send Email
Phone: +353 1 442 8820
Address:Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate
City: Dublin
State: Dublin
Country: Ireland

Antidepressants Market Overview and Regional Outlook Study 2016 – 2024

Antidepressants are drugs used for the treatment of depressive disorders including dysthymia, obsessive compulsive disorder, anxiety, chronic pain, eating disorders, and neuropathic pain. Depression is a medical disorder which is related to the brain. Symptoms of depression include feeling sad and tired, lacking energy, and having difficulty enjoying routine daily activities. According to CDC, depression affects about 1 in every 5 individuals in the U.S. According to WHO (World Health Organization), at present an estimated 350 million people worldwide are affected by depression. Depression affects 10% to 15% men and about 10% to 25% of women.

View Report-

The antidepressants market has been segmented based on the drug classes commonly used for the treatment of various types of depressive disorders. There are different types of antidepressant drugs available in the market such as selective serotonin reuptake inhibitors (SSRI), serotonin and noradrenaline reuptake inhibitors (SNRI), noradrenaline reuptake inhibitors, tricyclic antidepressants (TCA), reversible inhibitors of monoamine oxidase A (RIMA), tetracyclic antidepressants, etc. The different types of antidepressants are used in the treatment of depressive disorders. The different classes of antidepressants are as effective as each other, but some patients respond better to one antidepressant compared to another antidepressant. Side effects can also be different between these groups of antidepressants. Different types of depression disorders include dysthymic disorder, postpartum depression, psychotic depression, major or clinical depressive disorder, and seasonal affective disorder.

Factors driving the antidepressants market are declining side effects and rising efficacy of drugs in various classes as well as growing geriatric population where rate of mental illness is higher. However, the overall antidepressants market growth would decrease due to patent expiry of key antidepressants, fragile pipeline of new drugs, increasing number of generic drug alternatives, and growing prevalence of treatment-resistant psychiatric disorders.

Request Brochure-

Region wise, the global fermented ingredients market is segmented into five regions; North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the most dominant market for antidepressants due to the presence of a large patient population suffering from various types of anxiety disorders and depression. However, the antidepressants market in the U.S. is currently saturated, as several antidepressant drugs are available on prescription for the same indication. Hence, the future growth of the market would depend on introduction of efficacious drugs for new indications.

Moreover, loss of patent exclusivity, market maturity, generic infiltration, and shortened drug lifecycles are the additional factors that contribute to the decline in market growth in the region. Asia Pacific is expected to witness appreciable growth due to multiple factors such as high prevalence of psychiatric disorders and rapid economic growth in countries such as China, Japan, and Australia. Additionally, positive marketing approval for innovative medicines is likely to drive the market in the near future.

Request for TOC containing Tables and Figures:

Currently, the market is highly fragmented and competitive in nature due to the involvement of both large and small pharmaceutical companies. AstraZeneca plc, Eli Lilly and Company, Forest Laboratories, GlaxoSmithKline plc, H. Lundbeck A/S, Johnson & Johnson, Merck & Co., Inc., Pfizer, Inc. and Sanofi S.A. are major companies operating in the antidepressants market. Majority of the market players are focusing on expanding distribution network as well as expanding geographical presence, as Asia Pacific, the Middle East& Africa, and Latin America are developing regions with an increasing prevalence of various types of depressive disorders and improving economic conditions. Differences in clinical efficacy between drugs are generally small because most modern antidepressants work through a common biological mechanism. As a result, drug makers use direct-to-consumer advertising and tweak side effect profiles in order to differentiate their products.

Feed Antioxidants Market | Growth Worth is CAGR of about 4.8% | Application | Insight | Forecast to 2023

Market Overview:

Feed Antioxidants market is observing an exponential growth based on the high use in the feed industry. Additionally, the Feed Antioxidants market is growing due to increasing meat & meat products consumption. Moreover, growing demand for high-quality animal feed and increasing awareness regarding livestock health, among livestock holders, is driving the growth of global Feed Antioxidants market.

Click For Free a Sample Report @

Market Forecast:

The global Feed Antioxidants market is anticipated to boost with the rise in awareness regarding available benefits to livestock from the Feed Antioxidants. Additionally, increased demand for Feed Antioxidants from the bulk feed manufacturers to overcome the effect of feed oxidation is pushing the market growth. The developing economies of the Asia Pacific region, are witnessing a high demand for feed additives such as Feed Antioxidants, owing to high demand for meat and meat products.

Furthermore, advance processing methods & technologies, and high opportunities in developing countries are positively supporting the growth of the market. However, the toxicity caused by the use of synthetic chemicals used in feed to overcome oxidation of feed may hamper the Feed Antioxidants market over the review period. The market players are responding to these new opportunities by introducing new products, which are naturally prepared and have lesser side-effects on the livestock performanve, which has boosted the share of natural Feed Antioxidants in the global market. Nevertheless, all these factors are projected to lead to the estimated CAGR of 4.8% of the Feed Antioxidants market during the forecast period, 2019-2023. 

Downstream analysis:

The global Feed Antioxidants market is segmented into type and livestock.

By type, it is segmented into beta hydroxy acid, butylated hydroxytoluene, ethoxyquin, and others. Among all the types, the beta hydroxy acid segment is dominating the market.

By livestock, it is segmented into poultry, swine, ruminants, aquatic, and others. Among all, the poultry segment is dominating the market based on increased consumption of poultry and meat products, globally.

Competitive analysis:

The major players in the Feed Antioxidants market:

  • Cargill Inc. (U.S.)
  • I. du Pont de Nemours and Company (U.S.)
  • Alltech, Inc. (U.S.)
  • Adisseo France SAS (France)
  • Danisco A/S (Denmark)
  • Koninklijke DSM N.V (the Netherlands)
  • Kemin Europa NV (Belgium)
  • Perstorp Holding AB (Sweden)
  • Novus International, Inc. (U.S.)
  • Nutreco N.V. (the Netherlands)

Regional Analysis:

The global Feed Antioxidants Market is segmented into North America, Europe, Asia Pacific, and rest of the world (RoW). The Asia Pacific region is dominating the Feed Antioxidants market, followed by North America. Increasing livestock diseases, growing health awareness towards Feed Antioxidants, and increased consumption of meat products have surged the demand for Feed Antioxidants. Moreover, increased demand for superior quality animal feed is driving the market of Feed Antioxidants in the Asia Pacific region.

Furthermore, U.S. dominates the North America Feed Antioxidants market. Increased demand for meat products in North America is likely to boost the Feed Antioxidants market over the forecast period. Additionally, the major key players are actively involved in the research & development to enhance the product functionality.

Page 1 of 9387

Powered by WordPress & Theme by Anders Norén